Literature DB >> 26245565

Ebola: Embed research in outbreak response.

Trudie Lang1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26245565     DOI: 10.1038/524029a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  5 in total

1.  Saving lives without new drugs.

Authors:  Jon Cohen
Journal:  Science       Date:  2014-11-21       Impact factor: 47.728

2.  Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses.

Authors:  Diana F Florescu; Megan A Keck
Journal:  Expert Rev Anti Infect Ther       Date:  2014-08-13       Impact factor: 5.091

3.  Ebola: time to act.

Authors: 
Journal:  Nature       Date:  2014-09-11       Impact factor: 49.962

4.  First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses.

Authors:  Wendy Painter; Alice Robertson; Lawrence C Trost; Susan Godkin; Bernhard Lampert; George Painter
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

Review 5.  Diagnosis and treatment of adenovirus infection in immunocompromised patients.

Authors:  Susanne Matthes-Martin; Heidrun Boztug; Thomas Lion
Journal:  Expert Rev Anti Infect Ther       Date:  2013-09-27       Impact factor: 5.091

  5 in total
  9 in total

Review 1.  Insights from clinical research completed during the west Africa Ebola virus disease epidemic.

Authors:  Amanda Rojek; Peter Horby; Jake Dunning
Journal:  Lancet Infect Dis       Date:  2017-04-28       Impact factor: 25.071

2.  Antiviral Therapy during the Coronavirus Disease (COVID-19) Pandemic: Is It Appropriate to Treat Patients in the Absence of Significant Evidence?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2020 Mar-Apr

Review 3.  Offering patients more: how the West Africa Ebola outbreak can shape innovation in therapeutic research for emerging and epidemic infections.

Authors:  Amanda M Rojek; Peter W Horby
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-05-26       Impact factor: 6.237

4.  Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping review.

Authors:  Louise Sigfrid; Katherine Maskell; Peter G Bannister; Sharif A Ismail; Shelui Collinson; Sadie Regmi; Claire Blackmore; Eli Harriss; Kajsa-Stina Longuere; Nina Gobat; Peter Horby; Mike Clarke; Gail Carson
Journal:  BMC Med       Date:  2020-06-25       Impact factor: 8.775

5.  The remaining unknowns: a mixed methods study of the current and global health research priorities for COVID-19.

Authors:  Alice Norton; Arancha De La Horra Gozalo; Nicole Feune de Colombi; Moses Alobo; Juliette Mutheu Asego; Zainab Al-Rawni; Emilia Antonio; James Parker; Wayne Mwangi; Colette Adhiambo Wesonga; Kevin Marsh; Marta Tufet; Peter Piot; Trudie Lang
Journal:  BMJ Glob Health       Date:  2020-07

6.  ZikaPLAN: Zika Preparedness Latin American Network.

Authors:  A Wilder-Smith; R Preet; K E Renhorn; R A Ximenes; L C Rodrigues; T Solomon; J Neyts; L Lambrechts; H Willison; R Peeling; A K Falconar; A R Precioso; J Logan; T Lang; H P Endtz; M C Erasmus; E Massad
Journal:  Glob Health Action       Date:  2017       Impact factor: 2.640

7.  Preparing for the next Zika.

Authors:  Kendall Hoyt; Richard Hatchett
Journal:  Nat Biotechnol       Date:  2016-04       Impact factor: 54.908

8.  Confronting the Multidimensional Challenges of Research in the Context of Emerging Infectious Diseases in Brazil: The Example of Yellow Fever.

Authors:  Vivian I Avelino-Silva; Claudia Figueiredo-Mello; Luciana V B Casadio; Ana C S S Nastri; Izabel Marcilio; Ana F Ribeiro; Anna S Levin; Ester C Sabino
Journal:  Am J Trop Med Hyg       Date:  2020-03-26       Impact factor: 2.345

9.  EBOVAC-Salone: Lessons learned from implementing an Ebola vaccine trial in an Ebola-affected country.

Authors:  Thomas Mooney; Elizabeth Smout; Bailah Leigh; Brian Greenwood; Luisa Enria; David Ishola; Daniela Manno; Mohamed Samai; Macaya Douoguih; Deborah Watson-Jones
Journal:  Clin Trials       Date:  2018-06-12       Impact factor: 2.486

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.